ABCC1 and neuroblastoma: Taken together, these results suggest that the synergistic effect of 934 + vincristine, as well as 934 + paclitaxel, is mediated, at least in part, by inhibition of efflux transporters, which may have a clinical significance because high expression of ABCC1 is associated with worse clinical outcome in NB patients.